Uptake and Cytotoxicity of Chitosan Molecules and Nanoparticles: Effects of Molecular Weight and Degree of Deacetylation

Pharmaceutical Research

Volumn 21, Issue 2, 2004, Pages 344-353

  Huang, Min ^a   Khor, Eugene ^a   Lim, Lee Yong ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Chitosan; Cytotoxicity; Degree of deacetylation; Molecular weight; Uptake

Indexed keywords

CHITOSAN; FLUORESCEIN ISOTHIOCYANATE; NANOPARTICLE;

ARTICLE; BINDING AFFINITY; BIOTRANSFORMATION; CANCER CELL CULTURE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; DEACYLATION; DEPOLYMERIZATION; DRUG EFFECT; DRUG UPTAKE; FLUOROMETRY; GELATION; HUMAN; HUMAN CELL; IC 50; INFORMATION PROCESSING; KINETICS; LUNG CARCINOMA; MOLECULAR WEIGHT; POLYMERIZATION; PRIORITY JOURNAL;

ACETYLATION; ADJUVANTS, PHARMACEUTIC; CELL LINE, TUMOR; CELL SURVIVAL; CHITIN; CHITOSAN; DRUG CARRIERS; ENDOCYTOSIS; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; HUMANS; MICROSCOPY, CONFOCAL; MOLECULAR WEIGHT; NANOTECHNOLOGY; PARTICLE SIZE;

EID: 1242314681     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:PHAM.0000016249.52831.a5     Document Type: Article

References (32)

1. K. A. Janes, M. P. Fresneau, A. Marazuela, A. Fabra, and M. J. Alonso. Chitosan nanoparticles as delivery systems for doxorubicin. J. Control. Rel. 73:255-267 (2001).
2. H.-Q. Mao, K. Roy, V. L. Troung-Le, K. A. Janes, K. Y. Lin, Y. Wang, J. T. August, and K. W. Leong. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J. Control. Rel. 70:399-421 (2001).
3. L. Illum, I. Jabbal-Gill, M. Hinchcliffe, A. N. Fisher, and S. S. Davis. Chitosan as a novel nasal delivery system for vaccines. Adv. Drug Deliv. Rev. 51:81-96 (2001).
4. M. Huang, Z. S. Ma, E. Khor, and L.-Y. Lim. Uptake of FITC-chitosan nanoparticles by A549 cells. Pharm. Res. 19:1488-1494 (2002).
5. Z. S. Ma and L.-Y. Lim. Uptake of chitosan and associated insulin in the Caco-2 cell monolayers: a comparison between chitosan molecules and chitosan nanoparticles. Pharm. Res. 20:1812-1819 (2003).
6. H. S. Blair, J. Guthrie, T. K. Law, and P. Turkington. Chitosan and modified chitosan membranes. I. Preparation and characterization. J. Appl. Polym. Sci. 33:641-656 (1987).
7. K. M. Vårum, M. M. Mhyr, R. J. N. Hjerde, and O. Smidsrød. In vitro degradation rates of partially N-acetylated chitosans in human serum. Carbohydr. Res. 299:99-101 (1997).
8. E. Khor. Chitin: Fulfilling a Biomaterials Promise. Elsevier Science. Oxford, UK (2001).
9. D. F. Williams. Progress in biomedical engineering. 4. Definitions in biomaterials. In: Williams, D.F. Editor. Proceedings of a Consensus Conference of the European Society for Materials, Chester, UK. Elsevier, Amsterdam. (1987).
10. K. Y. Lee, W. S. Ha, and H. L. Park. Blood compatibility and biodegradability of partially N-acetylated chitosan derivatives. Biomaterials 16:1211-1216 (1995).
11. K. Tomihata and Y. Ikada. In vitro and in vivo degradation of films of chitin and its deacetylated derivatives. Biomaterials 18:567-575 (1997).
12. H. Zhang and S. H. Neau. In vitro degradation of chitosan by a commercial enzyme preparation: effect of molecular weight and degree of deacetylation. Biomaterials 22:1653-1658 (2001).
13. B. Carreño-Gómez and R. Duncan. Evaluation of the biological properties of soluble chitosan and chitosan microspheres. Int. J. Pharm. 148:231-240 (1997).
14. N. G. M. Schipper, K. M. Vårum, and P. Artursson. Chitosans as absorption enhancers for poorly absorbable drugs.1: influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelial (Caco-2) cells. Pharm. Res. 13:1686-1691 (1996).
15. Q.P. Peniston and E. L. Johnson. Process for depolymerization of chitosan. US Patent 3,922,260, November 25, 1975.
16. S. Hirano, Y. Kondo, and K. Fujii. Preparation of acetylation derivatives of modified chito-oligosaccharides by the depolymerisation of partially N-acetylated chitosan with nitrous acid. Carbohydr. Res. 144:338-341 (1985).
17. P. Calvo, C. Remuñán-López, J. L. Vila-Jato, and M. J. Alonso. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J. Appl. Polym. Sci. 63:125-132 (1997).
18. D. J. Giard. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J. Natl. Cancer Inst. 51:1417-1423 (1973).
19. T. Mosmann. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity. J. Immunol. Methods 65:55-63 (1983).
20. E. Borenfreund and J. A. Puerner. Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol. Lett. 24:119-124 (1985).
21. S. C. Tan. A study on the isolation and characterization of fungal chitosan. Thesis (M.Sc.), School of Biological Sciences, Faculty of Science, National University of Singapore (1998).
22. S. C. Tan, E. Khor, T. K. Tan, and S. M. Wong. The degree of deacetylation of chitosan: advocating the first derivative UV-spectrophotometry method of determination. Talanta 45:713-719 (1998).
23. C. P. Wan, C. S. Park, and B. H. S. Lau. A rapid and simple microfluorometric phagocytosis assay. J. Immunol. Methods 162:1-7 (1993).
24. S. Sahlin, J. Hed, and I. Rundquist. Differentiation between attached and ingested immune complexes by a fluorescence quenching cytofluorometric assay. J. Immunol. Methods 60:115-124 (1983).
25. T. Jung, W. Kamm, A. Breitenbach, E. Kaiserling, J. X. Xiao, and T. Kissel. Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake? Eur. J. Pharm. Biopharm. 50:147-160 (2000).
26. P. Jani, D. E. McCarthy, and A. T. Florence. Nanosphere and microsphere uptake via Peyer's patches: observation of the rate of uptake in the rat after a single oral dose. Int. J. Pharm. 86: 239-246 (1992).
27. M. D. Hughes, M. Hussain, Q. Nawaz, P. Sayyed, and S. Akhtar. The cellular delivery of antisense oligonucleotides and ribozymes. Drug Discov. Today 6:303-315 (2001).
28. Y. Yasuomi, S. Kazuya, N Makiya, Y. Fumiyoshi, Y. Kiyoshi, H. Mitsuru, and T. Yoshinobu. Pharmacokinetic analysis of in vivo disposition of succinylated proteins targeted to liver nonparenchymal cells via scavenger receptors: Importance of molecular size and negative charge density for in vivo recognition by receptors. J. Pharmacol. Exp. Ther. 301:467-477 (2002).
29. S. W. Chang, J. Y. Westcott, J. E. Henson, and N. F. Voelkel. Pulmonary vascular injury by polycations in perfused rat lungs. J. Appl. Physiol. 62:1932-1943 (1987).
30. H. M. Ekrami and W. C. Shen. Carbamylation decreases the cytotoxicity but not the drug-carrier properties of polylysines. J. Drug Target. 2:469-475 (1995).
31. L. Dekie, V. Toncheva, P. Dubruel, E. H. Schacht, L. Barrett, and L. W. Seymour. Poly-L-glutamic acid derivatives as vectors for gene therapy. J. Control. Rel. 65:187-202 (2000).
32. P. Ferruti, S. Knobloch, E. Ranucci, R. Duncan, and E. Gianasi. A novel modification of poly(L-lysine) leading to a soluble cationic polymer with reduced toxicity and with potential as a transfection agent. Macromol. Chem. Phys. 199:2565-2575 (1998).